tiprankstipranks
XOMA Royalty’s Third Quarter 2024 Financial Insights
PremiumCompany AnnouncementsXOMA Royalty’s Third Quarter 2024 Financial Insights
4M ago
Xoma reports Q3 EPS ($1.59), consensus (44c)
Premium
The Fly
Xoma reports Q3 EPS ($1.59), consensus (44c)
4M ago
Xoma Corp. (XOMA) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Xoma Corp. (XOMA) Q3 Earnings Cheat Sheet
4M ago
XOMA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsXOMA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7M ago
Xoma receives $8.1M milestone related to Day One’s sale of PRV
Premium
The Fly
Xoma receives $8.1M milestone related to Day One’s sale of PRV
9M ago
LadRx, ImmunityBio mutually agree to terminate Aldoxorubicin license
Premium
The Fly
LadRx, ImmunityBio mutually agree to terminate Aldoxorubicin license
9M ago
Dare Bioscience secures $22M in non-dilutive strategic royalty financing
PremiumThe FlyDare Bioscience secures $22M in non-dilutive strategic royalty financing
10M ago
Xoma initiated with an Outperform at Leerink
Premium
The Fly
Xoma initiated with an Outperform at Leerink
10M ago
Xoma earns $9M milestone as FDA grants approval of Day One’s NDA for OJEMDA
Premium
The Fly
Xoma earns $9M milestone as FDA grants approval of Day One’s NDA for OJEMDA
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100